Macau Gaming Revenue Falls 93% in May as Borders Stay Tight
(Bloomberg) -- Macau gaming revenue plunged again in May as casino operators await the opening of borders to spark a recovery after an unprecedented shutdown of the world's largest gambling hub.
- Gross gaming revenue was 1.76 billion patacas ($221 million) in May, down 93.2% from a year earlier, according to data from the Gaming Inspection & Coordination Bureau. It was slightly better than the median analyst estimate of a 95% fall, and follows a record 97% decline in April.
Key Insights
- The results for May represent the eighth straight month of declining revenue, coming after Macau had already been battered by a two-year-long trade war and months of Hong Kong protests. The slump underscores the difficult task of recovering from a 15-day shutdown in February aimed at containing the coronavirus outbreak.
- While the pandemic has been curbed in mainland China, Macau and Hong Kong, casinos are still left with empty gaming tables because of border and visa restrictions, resulting in losses of more than $1 million a day each. Analysts are hoping controls will be eased starting this month, followed by a summer recovery.
- Even with the loosening of restrictions, there will still be “a clear set of risks,” Sanford C. Bernstein analyst Vitaly Umansky wrote in a note last month. Health experts are concerned about a second wave of infections, protests are flaring up again in Hong Kong, and the Chinese economy's recovery has been slow as relations with the U.S. deteriorate.
Market Performance
- The Bloomberg Intelligence index of Macau casino operators declined 0.7% in May and rose 2.4% on Monday after the decline in gaming revenue turned out to be a tad less than forecast. Benchmark Hang Sang Index fell 6.8% in May and gained 3.4% on Monday.
Get More
- Click here for analysts' survey on Macau gaming
- May 28, Death of China's King of Gambling Gives Empire Reins to Daughter
- May 12, Macau Gaming Regulator Head Resigns as Casinos Face Crisis
©2020 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.